Natural modulators of the hallmarks of immunogenic cell death.
Autophagy
Cancer immunotherapy
Danger-associated molecular patterns
ER stress
Immunogenic cell death
Necroptosis
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
09
11
2018
accepted:
19
12
2018
pubmed:
8
1
2019
medline:
19
12
2019
entrez:
8
1
2019
Statut:
ppublish
Résumé
Natural compounds act as immunoadjuvants as their therapeutic effects trigger cancer stress response and release of damage-associated molecular patterns (DAMPs). These reactions occur through an increase in the immunogenicity of cancer cells that undergo stress followed by immunogenic cell death (ICD). These processes result in a chemotherapeutic response with a potent immune-mediating reaction. Natural compounds that induce ICD may function as an interesting approach in converting cancer into its own vaccine. However, multiple parameters determine whether a compound can act as an ICD inducer, including the nature of the inducer, the premortem stress pathways, the cell death pathways, the intrinsic antigenicity of the cell, and the potency and availability of an immune cell response. Thus, the identification of hallmarks of ICD is important in determining the prognostic biomarkers for new therapeutic approaches and combination treatments.
Identifiants
pubmed: 30615863
pii: S0006-2952(18)30515-X
doi: 10.1016/j.bcp.2018.12.016
pii:
doi:
Substances chimiques
Antineoplastic Agents, Phytogenic
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-70Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.